Evogliptin

未找到该活性成分的已注册品牌。

该活性成分暂无已收录的食物注意事项。

• 2,4-thiazolidinedione中等

  当 2,4-thiazolidinedione 与 Evogliptin 联合使用时，发生 低血糖 的风险或严重程度可能增加。

  专业视图

  The risk or severity of hypoglycemia can be increased when 2,4-thiazolidinedione is combined with Evogliptin.

• 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline中等

  7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline 可能增强 Evogliptin 的降血糖作用。

  专业视图

  7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Evogliptin.

• Acarbose中等

  当 Acarbose 与 Evogliptin 联合使用时，发生 低血糖 的风险或严重程度可能增加。

  专业视图

  The risk or severity of hypoglycemia can be increased when Acarbose is combined with Evogliptin.

• Acetohexamide中等

  Evogliptin 可能增强 Acetohexamide 的降血糖作用。

  专业视图

  Evogliptin may increase the hypoglycemic activities of Acetohexamide.

• Acetylsalicylic acid中等

  当 Acetylsalicylic acid 与 Evogliptin 联合使用时，发生 低血糖 的风险或严重程度可能增加。

  专业视图

  The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Evogliptin.

• Agmatine中等

  当 Agmatine 与 Evogliptin 联合使用时，发生 低血糖 的风险或严重程度可能增加。

  专业视图

  The risk or severity of hypoglycemia can be increased when Agmatine is combined with Evogliptin.

• AICA ribonucleotide中等

  当 AICA ribonucleotide 与 Evogliptin 联合使用时，发生 低血糖 的风险或严重程度可能增加。

  专业视图

  The risk or severity of hypoglycemia can be increased when AICA ribonucleotide is combined with Evogliptin.

• Albiglutide中等

  当 Albiglutide 与 Evogliptin 联合使用时，发生 低血糖 的风险或严重程度可能增加。

  专业视图

  The risk or severity of hypoglycemia can be increased when Albiglutide is combined with Evogliptin.

• Alclometasone中等

  当 Alclometasone 与 Evogliptin 联合使用时，发生 高血糖 的风险或严重程度可能增加。

  专业视图

  The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Evogliptin.

• Aldosterone中等

  当 Aldosterone 与 Evogliptin 联合使用时，发生 高血糖 的风险或严重程度可能增加。

  专业视图

  The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Evogliptin.